--- title: "12:37 ET Rosalind Franklin University Researcher Awarded $1.9M NIH Grant for Neurological Disease Research" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/273117925.md" description: "Rosalind Franklin University (RFU) announced that Dr. Hongkyun Kim has been awarded a $1.9 million NIH grant for his research on neurological diseases. The 5-year grant will support his work on the molecular regulation of CaV2 voltage-gated calcium channels, which are crucial for synaptic transmission. Abnormalities in these channels are linked to various neurological disorders. Dr. Kim's research aims to enhance understanding of these channels and their role in disease pathologies, furthering RFU's commitment to health and biomedical education." datetime: "2026-01-20T17:38:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273117925.md) - [en](https://longbridge.com/en/news/273117925.md) - [zh-HK](https://longbridge.com/zh-HK/news/273117925.md) --- > 支持的语言: [English](https://longbridge.com/en/news/273117925.md) | [繁體中文](https://longbridge.com/zh-HK/news/273117925.md) # 12:37 ET Rosalind Franklin University Researcher Awarded $1.9M NIH Grant for Neurological Disease Research , /PRNewswire/ -- Rosalind Franklin University (RFU) announced today that Hongkyun Kim, PhD, professor of cell biology and anatomy in RFU's Center for Cancer Cell Biology, Immunology and Infection, was awarded a 5-year NIH grant from the National Institute of Neurological Disorders and Stroke for a total of $1,911,417. The grant will fund Dr. Kim's research on "molecular and cellular regulation of CaV2 voltage-gated calcium channels." Dr. Kim's research addresses the dysregulation of human proteins linked to a wide range of diseases. He is looking at a key protein in synaptic transmission: the voltage-gated calcium channel. These channels at the synapse determine how strongly nerve cells communicate with each other. This research is vital because abnormalities in channel function or abundance are often the underlying cause of neurological disorders, such as epilepsies, migraines and pain. Dr. Kim joined RFU in 2008 from UCSF's Ernest Gallo Clinic and Research Center, where he completed his post-doctoral training and afterward became an associate researcher. His research focus has been the genetic and genomic approaches to understand the pathogenesis mechanisms of neurological and neuromuscular diseases. "Our favorite protein among proteins involved in synaptic transmission is the CaV2 voltage-gated calcium channel," Dr. Kim said. "The voltage-gated calcium channel is critical for neurotransmitter release at the synapse of neurons. Using _C. elegans_ as a model organism, we intend to identify and determine molecular components responsible for the abundance of these calcium channels." "Dr. Kim has amassed an impressive body of work in this field of neurological disorders," said Joseph DiMario, PhD, RFU's executive vice president for research. "This new NIH award is a recognition of his expertise in this domain and will further expand the understanding of this critical channel in these disease pathologies." **About RFU** Rosalind Franklin University of Medicine and Science is committed to serving humanity through the interprofessional education of health and biomedical professionals and the discovery of knowledge dedicated to improving wellness. The university embodies the spirit of inquiry and excellence modeled by its namesake, Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU encompasses the Chicago Medical School, College of Health Professions, College of Nursing, College of Pharmacy, School of Graduate and Postdoctoral Studies, and the Dr. William M. Scholl College of Podiatric Medicine. Learn more at rosalindfranklin.edu. Media Contact: Office of Marketing and Communications **\[email protected\]** SOURCE Rosalind Franklin University of Medicine and Science ## 相关资讯与研究 - [Fda issuance of a priority review voucher to the sponsor of a rare pediatric disease product application- federal register website](https://longbridge.com/zh-CN/news/281378968.md) - [ZAWYA: NYU Abu Dhabi and University of Denver Researchers identify promising small molecule inhibitor of brain disorders like parkinson’s disease](https://longbridge.com/zh-CN/news/281500635.md) - [Symeres and Ambagon collaborate for colorectal cancer molecules](https://longbridge.com/zh-CN/news/281331025.md) - [ZAWYA-PRESSR: Burjeel Medical City launches Neuro-Oncology Center](https://longbridge.com/zh-CN/news/281003303.md) - [AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial](https://longbridge.com/zh-CN/news/281509606.md)